• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

julieas@unimelb.edu.au

Credentials


Position
Professor & Director of Health Clinical Research
Melbourne School of Population and Global Health - Centres and Institutes
Education
PhD
The Open University
Post Graduate Diploma
University of Cambridge
Bachelors Degree
University of Melbourne
ORCID

0000-0002-2660-2013

Prof Julie Simpson

Professor & Director of Health Clinical Research
Melbourne School of Population and Global Health

548 Scholarly works
74 Projects

HIGHLIGHTS

  • 2026

    Research grants (ARC, NHMRC, MRFF)

    Innovative Approaches to Optimising Existing and New Antimalarial Therapies
  • 2023

    Journal article

    Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial
    DOI: 10.1016/S0140-6736(23)00278-7
  • 2021

    Journal article

    Benefits and Risks of Iron Interventions in Infants in Rural Bangladesh
    DOI: 10.1056/NEJMoa2034187
  • 2021

    Research grants (ARC, NHMRC, MRFF)

    Optimising Treatment and Prevention Strategies to Accelerate Malaria Elimination
  • 2020

    Research Grant

    ProTreat: An Adaptive and Rapid Implementation Trial of Novel Therapies to Prevent and Treat COVID19 Infection in High Risk Cancer Patients
  • 2020

    Journal article

    The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: A retrospective cohort study
    DOI: 10.1186/s12916-020-1497-0
  • 2018

    Journal article

    Investigating the efficacy of triple artemisinin-based combination therapies for treating plasmodium falciparum malaria patients using mathematical modeling
    DOI: 10.1128/AAC.01068-18
Julie Simpson

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Spatiotemporal trends in P. falciparum malaria and identification of high-risk villages in Eastern Myanmar: an 8-year observational study
    DOI: 10.1038/s41598-025-32065-z
  • 2026

    Journal article

    Inverse probability weighted estimation of dynamic treatment regimen means in sequential multiple assignment randomised trials with missing data: a simulation study
    DOI: 10.1186/s13063-026-09493-x
  • 2026

    Journal article

    Defining estimands in anaesthesia clinical trials: a scoping review and framework
    DOI: 10.1016/j.bja.2026.03.026
  • 2026

    Journal article

    Assessment of antibody responses to Anopheles SG6-P1 and Aedes N-term 34 kDa salivary peptides: a randomised human-challenge trial of controlled exposures to vector bites
    DOI: 10.1186/s12916-026-04732-z
  • 2026

    Journal article

    Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial
    DOI: 10.1093/cid/ciaf409
  • 2026

    Journal article

    The role of the spleen in red blood cell loss caused by malaria: A mathematical model
    DOI: 10.1371/journal.pcbi.1013865
  • 2026

    Journal article

    Quantification of cure for pharmacodynamic models of antimalarial drugs: Deterministic versus stochastic approaches
    DOI: 10.1002/bcp.70340
  • 2026

    Journal article

    Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial
    DOI: 10.1016/S1473-3099(25)00729-7

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224